Apheresis as Therapy
Aferetica is an Innovative Small and Medium-sized Enterprise (SME), founded by Managers with tens of years of experience in Dialysis, Intensive Care, Cardiology and Medical Devices.
The company proposes itself as a catalyst for the creation of a Network of Clinicians, Academics, Researchers and Institutions, to create and validate New Apheretic Therapies, even for unexplored clinical areas.
An integrated and innovative vision of apheretic therapies is the challenge to face for a real evolution of the cure.
Last updates
Save the Date WPT 2025
We’re very glad to announce the 4th Workshop Purification Therapies ‘From Research to Clinics: The End of the Beginning'
Towards Purification Therapies Workshop 2022
At the end of the year, Purification Therapies Journey 2021 came to an end.
The integrated PerLife(R) system with “PerSorb ECOS-300CY™” sorbent obtains CE certification and is ready to enter in the clinical practice.
CytoSorbents (USA) and Aferetica announce the European Union's approval for clinical use of the integrated PerLife® system and the "PerSorb ECOS-300CY ™" sorbent
Events
42nd Vicenza Course AKI-CRRT-ECOS and Critical Care Nephrology 2024
We’re waiting for you in Vicenza from June 11ᵗʰ to June 13ᵗʰ for the 17ᵗʰ PTJ 2024 event, the 42nd edition of the Vicenza Course AKI-CRRT-ECOS and Critical Care Nephrology 2024
Spring Meeting SITO 2024
Spring Meeting SITO in Rome is our 16th event of the PTJ 2024
Scandinavian Transplantation Society 2024
STS - Scandinavian Transplantation Society 2024 is our 15th event of the PTJ 2024!